IGF-1 Temporal Response refers to the dynamic change in the serum concentration of Insulin-like Growth Factor-1 (IGF-1) over a specific period following a physiological or therapeutic stimulus, such as the administration of Growth Hormone (GH) secretagogues. This measurement provides insight into the liver’s somatomedin response and the overall function of the somatotropic axis. Analyzing the temporal profile, rather than a single snapshot, is essential for optimizing growth hormone-related therapies.
Origin
The concept is derived from the established GH-IGF-1 axis, where GH secreted by the pituitary stimulates the liver to produce IGF-1, which mediates many of GH’s anabolic effects. The ‘temporal response’ aspect became relevant in clinical practice with the advent of GH-modulating peptides, requiring dynamic testing to ensure an effective, sustained physiological signal. It reflects the time-dependent nature of endocrine signaling.
Mechanism
Following stimulation, the liver increases transcription and translation of IGF-1, leading to a measurable rise in serum concentration over several hours. The mechanism of the temporal response involves the GH binding to its receptor, activating the JAK-STAT signaling pathway, which upregulates IGF-1 gene expression. Clinically, monitoring this response confirms the biological efficacy of the intervention and helps prevent excessive or insufficient somatotropic signaling.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.